X0306
4
2019-06-17
0
0001403708
Evoke Pharma Inc
EVOK
0001578770
D'Onofrio Matthew J
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 370
SOLANA BEACH
CA
92075
0
1
0
0
Exec VP, Chief Bus. Officer
Stock Option (Right to Buy)
3.07
2019-06-17
4
D
0
65000
A
2026-01-27
Common Stock
65000
0
D
Stock Option (Right to Buy)
3.04
2019-06-17
4
D
0
70687
A
2026-02-04
Common Stock
70687
0
D
Stock Option (Right to Buy)
3.04
2019-06-17
4
D
0
52500
A
2026-02-04
Common Stock
52500
0
D
Stock Option (Right to Buy)
2.36
2019-06-17
4
D
0
150000
A
2027-01-24
Common Stock
150000
0
D
Stock Option (Right to Buy)
2.43
2019-06-17
4
D
0
150000
A
2028-02-06
Common Stock
150000
0
D
Stock Option (Right to Buy)
2.94
2019-06-17
4
D
0
150000
A
2029-02-05
Common Stock
150000
0
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
48750
0.00
D
2026-01-27
Common Stock
48750
48750
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
53015
0.00
D
2026-02-04
Common Stock
53015
53015
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
39375
0.00
D
2026-02-04
Common Stock
39375
39375
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
112500
0.00
D
2017-01-24
Common Stock
112500
112500
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
112500
0.00
D
2028-02-06
Common Stock
112500
112500
D
Stock Option (Right to Buy)
0.62
2019-06-17
4
A
0
112500
0.00
D
2029-02-05
Common Stock
112500
112500
D
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date.
On June 17, 2019, the Issuer canceled an option granted on January 28, 2016. In exchange for the canceled option, the reporting person received 48,750 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date.
On June 17, 2019, the Issuer canceled an option granted on February 5, 2016. In exchange for the canceled option, the reporting person received 53,015 options to purchase common stock.
On June 17, 2019, the Issuer canceled an option granted on February 5, 2016. In exchange for the canceled option, the reporting person received 39,375 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2017, subject to the reporting person's continued service to the Issuer through each such vesting date.
On June 17, 2019, the Issuer canceled an option granted on January 25, 2017. In exchange for the canceled option, the reporting person received 112,500 options to purchase common stock.
The option grant date was February 7, 2018, subject to approval of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "Plan") by the Issuer's stockholders which occurred at the Issuer's annual stockholder meeting on April 26, 2018. The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2018, subject to the reporting person's continued service to the Issuer through each such vesting date. Notwithstanding the foregoing vesting schedule, in no event may the option be exercised prior to the earlier of (i) the date on which the Issuer receives marketing approval from the U.S. Food and Drug Administration of Gimoti, (ii) the second anniversary of the date of grant, or (iii) the date of a "change in control" under Section 2.9 of the Plan.
On June 17, 2019, the Issuer canceled an option granted on February 7, 2018. In exchange for the canceled option, the reporting person received 112,500 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date.
On June 17, 2019, the Issuer canceled an option granted on February 6, 2019. In exchange for the canceled option, the reporting person received 112,500 options to purchase common stock.
The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date.
/s/ Matthew J. D'Onofrio
2019-06-19